Tetracycline antibiotics. This product is a broad-spectrum antibacterial agent. Many Rickettsia, Mycoplasma, Chlamydia, and Spirochete are sensitive to this product. Enterococci are resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, Yersinia, etc. are also sensitive to this product. There is cross-resistance between this product and different varieties of tetracycline antibiotics. The mechanism of action of this product is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, inhibit the growth of the peptide chain and affect the synthesis of bacterial proteins.

Diclofenac is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid into prostaglandins. At the same time, it can also promote the combination of arachidonic acid with triglycerides (triacylglycerols), reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac is a stronger non-steroidal anti-inflammatory drug, and its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

Dilate coronary arteries, improve myocardial ischemia, and improve heart function; inhibit platelet aggregation, enhance fibrinolysis, reduce blood viscosity, improve blood flow change indicators, normalize blood quality, and improve microcirculation deficiency; repair damaged vascular endothelium. Relieve headaches, dizziness, limb numbness, etc.

It can calm the mind, relieve pain, and awaken the brain, enhance the myocardium and chest's ability to withstand hypoxia, and improve the brain's blood and oxygen supply.

Prevent and treat arteriosclerosis, scavenge oxygen free radicals, enhance human immunity, and promote the proliferation of glial cells; lower the levels of total cholesterol, triglycerides, low-density lipoprotein and very low-density lipoprotein in the blood, increase the level of high-density lipoprotein, and treat hyperlipidemia.

It has the effect of resisting α-adrenaline receptors, directly dilating peripheral blood vessels, reducing the level of renin activity and angiotensin in the blood of hypertensive patients, and lowering blood pressure.

Tetracycline antibiotics. This product is a broad-spectrum antibacterial agent. Many Rickettsia, Mycoplasma, Chlamydia, and Spirochete are sensitive to this product. Enterococci are resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, Yersinia, etc. are also sensitive to this product. There is cross-resistance between this product and different varieties of tetracycline antibiotics. The mechanism of action of this product is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, inhibit the growth of the peptide chain and affect the synthesis of bacterial proteins.